Mary Wilson
Well-known member
1. OVERVIEW
Produced on 25 July 2023
This report provides a global overview of the mpox[SUP]1[/SUP] epidemiological situation as reported to WHO as of 24 July 2023. The report focuses on laboratory confirmed cases[SUP]2[/SUP] as defined by the WHO’s working case definition published in the Surveillance, case investigation and contact tracing for monkeypox interim guidance. Note that countries may use their own case definitions separate from those outlined in the above document. This report should be considered in the context of other WHO information products associated with the 2022-23 mpox outbreak, and mpox in general:
Since 1 January 2022, cases of mpox have been reported to WHO from 113 Member States across all 6 WHO regions. As of 24 July 2023 at 17h CEST, a total of 88,600 laboratory confirmed cases and 1,087 probable cases, including 152 deaths, have been reported to WHO. Since 13 May 2022, a high proportion of these cases have been reported from countries without previously documented mpox transmission. This is the first time that cases and sustained chains of transmission have been reported in countries without direct or immediate epidemiological links to areas of West or Central Africa.
With the exception of countries[SUP]3,4[/SUP] in West and Central Africa, the ongoing outbreak of mpox continues to primarily affect men who have sex with men (MSM). At present there is no signal suggesting sustained transmission beyond these networks.
Confirmation of one case of mpox, in a country, is considered an outbreak. The unexpected appearance of mpox in several regions in the initial absence of epidemiological links to areas in West and Central Africa, suggests that there may have been undetected transmission for some time.
WHO assesses the global risk as Moderate. Regionally, WHO assesses the risk in the Moderate in the African Region, Eastern Mediterranean Region, European Region and Region of the Americas, and Low in theSouth-East Asia Region and Western Pacific Region. The IHR Emergency Committee on the multi-country outbreak of mpox held its fifth meeting on 10 May 2023. Having considered the views of committee members and advisors as well as other factors in line with the International Health Regulations (2005), the WHO Director-General determined that this outbreak no longer constitutes a public health emergency of international concern and issued revised temporary recommendations for a transitionary period towards a long-term mpox control strategy.
It should be noted that at the present stage of the 2022-23 global mpox outbreak, where reported cases are low, frequency of reporting of cases has decreased substantially. For this reason, there are often significant delays between case detection and reporting at the global level, and data should be interpreted in light of this. ...
https://worldhealthorg.shinyapps.io/mpx_global/#21_Epidemic_curves
Produced on 25 July 2023
This report provides a global overview of the mpox[SUP]1[/SUP] epidemiological situation as reported to WHO as of 24 July 2023. The report focuses on laboratory confirmed cases[SUP]2[/SUP] as defined by the WHO’s working case definition published in the Surveillance, case investigation and contact tracing for monkeypox interim guidance. Note that countries may use their own case definitions separate from those outlined in the above document. This report should be considered in the context of other WHO information products associated with the 2022-23 mpox outbreak, and mpox in general:
- The biweekly Situation Report provides a comprehensive update of the mpox situation and response activities across a variety of domains such as epidemiology, clinical management and communications, replacing the previous Disease Outbreak News format;
- This global epidemiological report provides in-depth epidemiological information about the mpox situation, based primarily on case report forms provided by Member States to WHO under Article 6 of the International Health Regulations (IHR 2005).
Since 1 January 2022, cases of mpox have been reported to WHO from 113 Member States across all 6 WHO regions. As of 24 July 2023 at 17h CEST, a total of 88,600 laboratory confirmed cases and 1,087 probable cases, including 152 deaths, have been reported to WHO. Since 13 May 2022, a high proportion of these cases have been reported from countries without previously documented mpox transmission. This is the first time that cases and sustained chains of transmission have been reported in countries without direct or immediate epidemiological links to areas of West or Central Africa.
With the exception of countries[SUP]3,4[/SUP] in West and Central Africa, the ongoing outbreak of mpox continues to primarily affect men who have sex with men (MSM). At present there is no signal suggesting sustained transmission beyond these networks.
Confirmation of one case of mpox, in a country, is considered an outbreak. The unexpected appearance of mpox in several regions in the initial absence of epidemiological links to areas in West and Central Africa, suggests that there may have been undetected transmission for some time.
WHO assesses the global risk as Moderate. Regionally, WHO assesses the risk in the Moderate in the African Region, Eastern Mediterranean Region, European Region and Region of the Americas, and Low in theSouth-East Asia Region and Western Pacific Region. The IHR Emergency Committee on the multi-country outbreak of mpox held its fifth meeting on 10 May 2023. Having considered the views of committee members and advisors as well as other factors in line with the International Health Regulations (2005), the WHO Director-General determined that this outbreak no longer constitutes a public health emergency of international concern and issued revised temporary recommendations for a transitionary period towards a long-term mpox control strategy.
It should be noted that at the present stage of the 2022-23 global mpox outbreak, where reported cases are low, frequency of reporting of cases has decreased substantially. For this reason, there are often significant delays between case detection and reporting at the global level, and data should be interpreted in light of this. ...
https://worldhealthorg.shinyapps.io/mpx_global/#21_Epidemic_curves